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The ﬁrst structural representative of the domain of unknown function DUF2006
family, also known as Pfam family PF09410, comprises a lipocalin-like fold with
domain duplication. The ﬁnding of the calycin signature in the N-terminal
domain, combined with remote sequence similarity to two other protein families
(PF07143 and PF08622) implicated in isoprenoid metabolism and the oxidative
stress response, support an involvement in lipid metabolism. Clusters of
conserved residues that interact with ligand mimetics suggest that the binding
and regulation sites map to the N-terminal domain and to the inter-
domain interface, respectively.
1. Introduction
In an effort to extend the structural coverage of proteins for which
the biological function is unknown and cannot be deduced by
homology (domains of unknown function; DUFs), targets were
selected from Pfam protein family PF09410 (DUF2006). Here, we
report the crystal structure of NE1406, the ﬁrst structural repre-
sentation of this family, which was determined using the semi-
automated high-throughput pipeline of the Joint Center for
Structural Genomics (JCSG; Lesley et al., 2002) as part of the NIGMS
Protein Structure Initiative (PSI). The NE1406 gene of Nitrosomonas
europaea, an obligate chemolithoautotroph, encodes a protein with a
molecular weight of 40.1 kDa (residues 1–356) and a calculated
isoelectric point of 5.0.
2. Materials and methods
2.1. Protein production and crystallization
Clones were generated using the polymerase incomplete primer
extension (PIPE) cloning method (Klock et al., 2008). The gene
encoding NE1406 (GenBank NP_841447, gi|30249377, Swiss-Prot
Q82US3) was ampliﬁed by polymerase chain reaction (PCR) from
N. europaea strain ATCC 19718 genomic DNAusing PfuTurbo DNA
polymerase (Stratagene) and I-PIPE (Insert) primers (forward
primer 50-ctgtacttccagggcATGCGTTACTTATGGATACTGTTG-30,
reverse primer 50-aattaagtcgcgttaCATCGATAACGGACGTACG-30;
target sequence in upper case) that included sequences for the
predicted 50 and 30 ends. The expression vector pSpeedET, which
encodes an amino-terminal tobacco etch virus (TEV) protease-
cleavable expression and puriﬁcation tag (MGSDKIHHHHHHEN-
LYFQ/G), was PCR-ampliﬁed with V-PIPE (Vector) primers. V-PIPE
and I-PIPE PCR products were mixed to anneal the ampliﬁed DNA
fragments together. Escherichia coli GeneHogs (Invitrogen) com-
petent cells were transformed with the V-PIPE/I-PIPE mixture and
dispensed onto selective LB-agar plates. The cloning junctions were
conﬁrmed by DNA sequencing. Using the PIPE method, the part of
the gene encoding residues Met1–Pro22 was deleted. Expression was
performed in a selenomethionine-containing medium with suppres-
sion of normal methionine synthesis. At the end of fermentation,
lysozyme was added to the culture to a ﬁnal concentration of
250 mgm l
 1 and the cells were harvested and frozen. After one
freeze–thaw cycle, the cells were sonicated in lysis buffer [50 mM
HEPES pH 8.0, 50 mM NaCl, 10 mM imidazole, 1 mM tris(2-car-boxyethyl)phosphine–HCl (TCEP)] and the lysate was clariﬁed by
centrifugation at 32 500g for 30 min. The soluble fraction was passed
over nickel-chelating resin (GE Healthcare) pre-equilibrated with
lysis buffer, the resin was washed with wash buffer [50 mM HEPES
pH 8.0, 300 mM NaCl, 40 mM imidazole, 10%(v/v) glycerol, 1 mM
TCEP] and the protein was eluted with elution buffer [20 mM
HEPES pH 8.0, 300 mM imidazole, 10%(v/v) glycerol, 1 mM TCEP].
The eluate was buffer-exchanged with TEV buffer (20 mM HEPES
pH 8.0, 200 mM NaCl, 40 mM imidazole, 1 mM TCEP) using a PD-10
column (GE Healthcare) and incubated with 1 mg TEV protease per
15 mg of eluted protein. The protease-treated eluate was run over
nickel-chelating resin (GE Healthcare) pre-equilibrated with HEPES
crystallization buffer (20 mM HEPES pH 8.0, 200 mM NaCl, 40 mM
imidazole, 1 mM TCEP) and the resin was washed with the same
buffer. The ﬂowthrough and wash fractions were combined and
concentrated by centrifugal ultraﬁltration (Millipore) to19.4 mg ml
 1
for crystallization trials. NE1406 was crystallized using the nano-
droplet vapor-diffusion method (Santarsiero et al., 2002) with stan-
dard JCSG crystallization protocols (Lesley et al., 2002). Sitting drops
composed of 200 nl protein mixed with 200 nl crystallization solution
were equilibrated against a 50 ml reservoir at 293 K for 50 d prior to
harvest. The crystallization reagent consisted of 1.4 M ammonium
sulfate and 0.1 M CHES [2-(N-cyclohexylamino)ethanesulfonic acid]
pH 9.0. Glycerol was added to the crystal to a ﬁnal concentration
of 10%(v/v) as a cryoprotectant. Initial screening for diffraction
was carried out using the Stanford Automated Mounting system
(SAM; http://smb.slac.stanford.edu/facilities/hardware/SAM/UserInfo;
Cohen et al., 2002) at the Stanford Synchrotron Radiation Light-
source (SSRL; Menlo Park, California, USA). Diffraction data from a
plate-shaped crystal with approximate dimensions 0.2   0.1  
0.05 mm mounted in a nylon loop were indexed in the orthorhombic
space group P212121 (Table 1). The oligomeric state of NE1406 was
determined to be a monomer using a 0.8   30 cm Shodex Protein
KW-803 column (Thomson Instruments) pre-calibrated with gel-
ﬁltration standards (Bio-Rad). Protein concentrations were deter-
mined using the Coomassie Plus assay (Pierce).
2.2. Data collection, structure solution and refinement
Multiple-wavelength anomalous diffraction (MAD) data were
collected at the APS on beamline 23-ID-D at wavelengths corre-
sponding to the inﬂection ( 1), high-energy remote ( 2) and peak ( 3)
points of the Se K absorption spectrum. The data sets were collected
at 100 K using a MAR Mosaic300 CCD detector (Rayonix). The
MAD data were integrated and reduced using MOSFLM (Leslie,
1992) and scaled with the program SCALA (Collaborative Compu-
tational Project, Number 4, 1994). Phasing was performed with
SOLVE (Terwilliger & Berendzen, 1999), with a mean ﬁgure of merit
of 0.28 with eight selenium sites (no selenium site was found for the
disordered C-terminal SeMet356 for either chain). Density modiﬁ-
cation with RESOLVE (Terwilliger, 2002) was followed by auto-
mated model building with ARP/wARP (Cohen et al., 2004). Model
completion and reﬁnement were carried out with Coot (Emsley &
Cowtan, 2004) and REFMAC 5.2 (Winn et al., 2003) using data set  1.
Reﬁnement included experimental phase restraints in the form of
Hendrickson–Lattman coefﬁcients from SOLVE, NCS restraints
(positional weights of 0.5 and 5.0 and thermal weights of 2.0 and 10.0
for the main-chain and side-chain atoms, respectively) and TLS
reﬁnement with one group per chain. NCS restraints were applied
as two sets: to the N-terminal residues 24–74 and the C-terminal
residues 83–351. Data-collection and reﬁnement statistics are
summarized in Table 1.
2.3. Validation and deposition
Analysis of the stereochemical quality of the model was accom-
plished using AutoDepInputTool (Yang et al., 2004), MolProbity
(Davis et al., 2007), SFCHECK 4.0 (Collaborative Computational
Project, Number 4, 1994) and WHAT IF 5.0 (Vriend, 1990). Protein
quaternary structure was analyzed using the PISA server (Krissinel &
Henrick, 2007). Fig. 1(b) was adapted from an analysis using PDBsum
(Laskowski et al., 2005) and all other ﬁgures were prepared with
PyMOL (DeLano Scientiﬁc). Atomic coordinates and experimental
structure factors for NE1406 at 2.0 A ˚ resolution have been deposited
in the PDB with code 2ich.
3. Results and discussion
3.1. Overall structure
The crystal structure of a truncated version of NE1406 (Fig. 1a)
was determined to 2.0 A ˚ resolution using the MAD phasing tech-
nique. Data-collection, model and reﬁnement statistics are summar-
ized in Table 1. The ﬁnal model includes 643 residues in two protein
molecules (A and B), two CHES molecules, three glycerol molecules,
one sulfate ion and 394 water molecules in the asymmetric unit. No
electron density was observed for Gly0 (from the puriﬁcation tag),
Val23 (the ﬁrst residue after Gly0), Thr75–Pro82 and Arg352–
SeMet356 in chain A or for Thr75–Asp80 and Pro353–SeMet356 in
chain B. The side-chain atoms of Leu24, Arg144, Glu169, Gln200,
structural communications
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Table 1
Summary of crystal parameters, data-collection and reﬁnement statistics for
NE1406 (PDB code 2ich).
Values in parentheses are for the highest resolution shell.
 1 MADSe  2 MADSe  3 MADSe
Data collection
Space group P212121
Unit-cell parameters (A ˚ ) a = 63.27, b = 95.57, c = 121.75
Wavelength (A ˚ ) 0.9794 0.9493 0.9792
Resolution range (A ˚ ) 29.20–2.00
(2.05–2.00)
29.20–2.00
(2.05–2.00)
29.10–2.00
(2.05–2.00)
No. of observations 178048 177082 176130
No. of unique reﬂections 49800 49531 49656
Completeness (%) 98.4 (95.9) 97.9 (95.0) 98.4 (95.6)
Mean I/ (I) 9.3 (2.1) 9.8 (2.3) 8.8 (2.0)
Rmerge on I† 0.117 (0.599) 0.109 (0.535) 0.121 (0.602)
Model and reﬁnement statistics
Resolution range (A ˚ ) 29.2–2.00
No. of reﬂections (total) 49646‡
No. of reﬂections (test) 2528
Completeness (%) 98.0
Data set used in reﬁnement  1
Cutoff criterion |F|>0
Rcryst§ 0.182
Rfree} 0.232
Stereochemical parameters
Restraints (r.m.s.d. observed)
Bond angles ( ) 1.65
Bond lengths (A ˚ ) 0.018
Average isotropic B value (A ˚ 2) 27.9††
ESU‡‡ based on Rfree (A ˚ ) 0.16
Protein residues/atoms 643/5142
Water molecules/ions/other solvent§§ 394/1/5
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Typically, the number of
unique reﬂections used in reﬁnement is slightly less that the total number that were
integrated and scaled. Reﬂections are excluded owing to systematic absences, negative
intensities and rounding errors in the resolution limits and unit-cell parameters. § Rcryst
=
P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj, where Fcalc and Fobs are the calculated and observed
structure-factor amplitudes, respectively. } Rfree isthe same as Rcryst but for 5.1% of the
total reﬂections chosen at random and omitted from reﬁnement. †† This value
represents the total B that includes TLS and residual B components. ‡‡ Estimated
overall coordinate error (Collaborative Computational Project, Number 4, 1994;
Cruickshank, 1999). §§ Two CHES and three glycerol molecules.Asp222 from chain A and Leu24, Gln89 and Arg352 from chain B
were omitted owing to poor electron density. The two chains are
nearly identical, with an r.m.s.d. of 0.30 A ˚ over 320 C
  atoms (0.60 A ˚
over all 2524 equivalent atoms). The Matthews coefﬁcient (VM;
Matthews, 1968) is 2.35 A ˚ 3 Da
 1 and the estimated solvent content is
47.3%. The Ramachandran plot produced by MolProbity (Davis et
al., 2007) shows that 98 and 100% of the residues are in favored and
allowed regions, respectively.
SCOP classiﬁes NE1406 as an all-  protein with an AttH-like fold
characterized by two ﬂattened, orthogonally packed,  -barrels of
lipocalin-like topology (http://scop.mrc-lmb.cam.ac.uk/scop/data/
scop.b.c.bai.b.b.b.html). Lipocalins (PF00061) are an increasingly
diverse family of predominantly small, single-domain, secreted
proteins exhibiting high afﬁnity and selectivity for hydrophobic
molecules. Structurally, lipocalins form a subset of the calycin
superfamily, which additionally includes avidins and fatty-acid
binding proteins (FABPs) (Flower et al., 1993; Pfam clan CL0116).
Calycins are an example of a superfamily with members sharing
structural similarities that cannot be detected at the sequence level.
The calycin core fold comprises an eight-stranded calyx-shaped
antiparallel  -barrel which opens toward one end, where the binding
site is located. In the case of lipocalins and avidins, the core fold is
maintained and differences are observed in the loop lengths and
compactness of the barrel. In FABPs, the core calycin fold is
supplemented by two additional  -strands and two short helices that
pack on top of the lipid-binding cavity. In all cases, a short 310-helix
caps the barrel at one end, which is also latched by a conserved
cation–  interaction involving a tryptophan from the ﬁrst  -strand
and a lysine or arginine residue from the ﬁnal  -strand of the barrel.
Both of these residues additionally form hydrogen bonds to main-
chain atoms in the 310-helix (Flower et al., 2000).
The N-terminal domain of NE1406 (residues 24–220) comprises 13
 -strands arranged in the form of a ﬂattened barrel with a 310-helix
(H1 in Fig. 1) capping the barrel at one end (Fig. 1a). The C-terminal
structural communications
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Figure 1
Crystal structure of NE1406 from N. europaea.( a) Stereo ribbon diagram of the NE1406 monomer (chain A) color-coded from the N-terminus (blue) to the C-terminus
(red). Helices H1–H3 and  -strands  1– 23 are indicated. (b) Diagram showing the secondary-structure elements of NE1406 (chain A) superimposed on its sequence. The
labeling of secondary-structure elements is in accord with PDBsum (http://www.ebi.ac.uk/pdbsum), where  -helices are sequentially labeled (H1, H2, H3 etc.),  -strands are
labeled (A, B, Cetc.)according to the  -sheets to which they are assigned,  -turns and -turns are designated by Greek letters ( ,  ) and -hairpins by red loops.For NE1406,
the 310-helices (H1–H3),  -strands in  -sheets (A and B, comprising strands  1– 13 and  14– 23, respectively ),  -turns ( ) and  -turns ( ) are indicated. Dashed lines
indicate sections of sequence in the construct that are not modeled in the structure.domain (residues 221–352) is arranged perpendicular to the long axis
of the N-terminal barrel and comprises ten  -strands. It can be
superimposed on the N-terminal domain with a C
  r.m.s.d. of 2.4 A ˚
over 105 residues (Fig. 2a), suggesting gene duplication, although the
sequence identity of only 9% is nonsigniﬁcant (Fig. 2b). Strands  5–
 6 are absent from the C-terminal domain, while  11 is replaced by
another 310-helix (H3 in Fig. 2b). The 310-helix cap of the N-terminal
barrel is replaced by two longer strands,  18– 19 (in the C-terminal
domain), that extend over one end of the barrel (Figs. 1a and 2).
3.2. Detection of the calycin superfamily signature
A search with FATCAT (Ye & Godzik, 2004) using the entire
NE1406 structure gave no signiﬁcant hits. Individually, the N- and
C-terminal domains both showed structural similarity to a variety of
 -barrel proteins, including outer membrane proteins (PDB codes
2erv, 2jmm, 1k24 and 1p4t), avidin-related and streptavidin-related
proteins (PDB codes 1avd, 1wbi, 1y52, 2ciq, 2uyw and 1stp), fatty-
acid binding proteins (PDB codes 1g5w and 2q9s), nitrophorin (PDB
codes 1d2u and 1u17) and a retinoic acid-binding protein (PDB code
1blr). The best score was for the outer membrane protein PagL from
Pseudomonas aeruginosa (PDB code 2erv), which gave a C
  r.m.s.d.
of 3.4 A ˚ over 198 residues with a sequence identity of only 3%.
This calycin-family signature in NE1406 (Fig. 3b) is conserved in
the DUF2006 family. In the N-terminal domain of NE1406, the
Arg214 side chain from  13 interacts with main-chain residues in
both  1 and the N-terminal 310-helix, whereas hydrogen bonding of
the Trp50 indole to the 310-helix is mediated via a glycerol molecule
(Fig. 3b). Although the calycin signature is absent from the NE1406
C-terminal domain (Fig. 2), its presence in the N-terminal domain
served to direct our analysis towards calycin-superfamily members.
Analysis of the structural superposition of NE1406 with members
of the calycin superfamily revealed a number of systematic differ-
ences (Figs. 3c and 3d). The  -sheets forming the NE1406  -barrel are
both longer and ﬂatter than those in lipocalins, resulting in a narrower
opening at the bottom of the barrel where the lipocalin-binding site
would reside. The difference is even more pronounced when NE1406
is compared with avidins (PF01382; Fig. 3d), which have barrels that
are more circular and compact than in lipocalins. In this respect,
NE1406 resembles FABPs, which also exhibit a barrel that is ﬂatter
and more elliptical than in lipocalins. However, NE1406 lacks two
additional helices at the top of the barrel that are a characteristic of
FABPs. Secondary-structure elements, such as the long C-terminal
 -helix characteristic of most lipocalin-like calycins, e.g. nitrophorin
(PF02087; Flower et al., 2000; Skerra, 2000), are also absent from
NE1406. Finally, the calycin signature residues are in different
conformations to those typically described for calycins, with Trp50
structural communications
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Figure 2
NE1406 exhibits domain duplication. (a) Stereo ribbon diagram of the N-terminal domain (residues 24–220, blue) of NE1406 superimposed onto the C-terminal domain
(residues 221–352, gray). (b) Structure-guided alignment of the N- and C-terminal domains of NE1406. Secondary-structure elements are indicated in blue and gray for the
N- and C-terminal domains, respectively. Identical residues are boxed in orange and conservative substitutions in purple. Ala74 is underlined to denote the eight-residue
break in the chain between Ala74 and Ser83. The missing region was not modeled owing to poor electron density and is likely to be ﬂexible.adopting a different rotamer in NE1406 than in
calycins and Arg214 not adopting a fully extended
conformation.
3.3. Similarities and differences with lipocalins
NE1406 is likely to provide the ﬁrst structural
template for two other protein families. A search
with HHpred (Soding et al., 2005) against Pfam
gave E values of 1.0   10
 15 and 1.5   10
 7 for
protein families PF07143 and PF08622, respec-
tively. PF07143 is a prokaryotic family of hydro-
xyneurosporene synthases that are implicated in
carotene metabolism, while PF08622 is a family of
fungal proteins that inhibit the generation of
reactive oxygen species and promote survival
during oxidative stress. The role of isoprenoids in
photoprotection in plants (Penuelas & Munne-
Bosch, 2005) and antioxidant defence in other
eukaryotes (Tapiero et al., 2004; Rao & Rao,
2007) has been well documented. A number of
lipocalins, such as apolipoprotein D (ApoD;
Sanchez et al., 2006; Charron et al., 2008;
Eichinger et al., 2007), neutrophil gelatinase-
associated lipocalin (Roudkenar et al., 2008;
Goetz et al., 2002) and  1-microglobulin (Olsson
et al., 2008; Schonfeld & Wojtczak, 2008), provide
protection against oxidative stress by means of
isoprenoids such as carotene. Other members of
the calycin superfamily, such as avidins
(PF01382), are not involved in this response. We
therefore searched for other indications that
NE1406 might be related to the lipocalin/cytosolic
fatty-acid binding protein family (PF00061).
Lipocalins have been likened to antibodies
because of the high degree of structural plasticity
that their binding sites exhibit, with numerous
examples in which structural consolidation occurs
upon binding (for areview, seeSkerra, 2008). As a
result, the lipocalin fold has been employed in a
number of protein-engineering studies (Beste et
structural communications
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Figure 3
Similarities and differences between NE1406 and the
calycin superfamily. (a) Stereo ribbon diagram of the
binding sites for the two buffer molecules 2-(N-cyclohex-
ylamino)ethanesulfonic acid (CHES) and glycerol (GOL).
Conserved residues are indicated. (b) NE1406 exhibits the
calycin-superfamily structural signature. Stereo ribbon
diagram of the N-terminal domain of NE1406 showing the
stacked arginine and tryptophan residues characteristic of
the calycin fold (Flower et al., 2000). Hydrogen bonds are
indicated by dashed lines. A glycerol molecule (cyan)
mediates bonding of Trp50 to the 310-helix. (c) Ribbon
diagrams depicting the front and back view of NE1406
(PDB code 2ich, residues 24–220; gray) superposed with
nitrophorin 4 from Rhodnius prolixus (PDB code 1d2u,
residues 22–205; red. The heme ligand for nitrophorin 4 is
colored cyan. (d) Ribbon diagrams depicting the front and
back view of NE1406 (PDB code 2ich, residues 24–220;
grey) superposed with avidin from Gallus gallus (PDB code
1avd, residues 3–125; pink). The Trp-Arg signatures are
represented as sticks. The biotin ligand for avidin is shown
in cyan.al., 1999; Korndorfer et al., 2003). In the NE1406 crystal structure, the
two lipocalin-like barrels lack the large internal cavity that is typical
of lipocalins and also the long structurally ﬂexible loops at the open
end of the  -barrel (Skerra, 2000). In fact, only one of the  -barrel
domains of NE1406 harbors a small glycerol molecule from the
crystallization solution as a ligand. However, the complete inter-
nalization of the glycerol molecule in the NE1406 structure suggests
that the N-terminal lipocalin-like barrel might adopt different
conformations in the presence of a natural ligand. We therefore
propose that this region, which encompasses the calycin signature,
acts as a ligand-binding site, the shape and accessibility of which may
change with natural ligands.
The ability to form dimers is another feature of the lipocalin family,
with ligand presence inﬂuencing oligomerization (Grzyb et al., 2006).
Analytical size-exclusion chromatography shows that NE1406 forms
a monomer in solution, whereas crystal-packing analysis suggests a
dimer with a total buried surface area of 1290 A ˚ 2 per monomer.
While it is possible that dimerization of NE1406 is modulated by
ligand binding, the relative orientation of the two protein domains
within the polypeptide chain could also be subject to regulation by a
second ligand. The two barrels are stabilized in a perpendicular
orientation with respect to each other. The mainly aromatic and
hydrophobic residues implicated in the interaction with CHES are
highly or strictly conserved among DUF2006 homologs, suggesting
that the domain interface plays a functional role. As with the glycerol
molecule bound within the N-terminal barrel, the CHES molecule is
also fully enclosed within NE1406 with no exposure to solvent,
suggesting some ﬂexibility at the interdomain interface to accom-
modate ligands. Ligand binding at the domain interface might act to
regulate the shape of the binding cavity within one or both of the  -
barrels in a similar manner to the regulation by dimerization
observed in lipocalins.
Finally, some lipocalins, such as the bacterial lipocalin (Blc), ApoD
and lazarillo, are known to be peripherally anchored to biological
membranes, where they are thought to play a role in membrane
biogenesis and repair (Bishop, 2000; Eichinger et al., 2007). Expressed
under conditions known to exert stress on the bacterial envelope, Blc
from E. coli has a high afﬁnity for lysophospholipids (LPLs), which
may also be bound inside the  -barrel and are thought to be involved
in cell-envelope LPL transport (Campanacci et al., 2006). Although
the exact mechanisms of transperiplasmic movement of lipids
between inner and outer membranes are largely unknown, ATP-
binding cassette transporters are involved in this process (Doerrler et
al., 2004).
As expected, a search with PROFtmb (Bigelow et al., 2004) shows
that NE1406 is not predicted to be a transmembrane  -barrel (Z
score 2.9). However, calculations with the program PPM (Lomize et
al., 2006) suggest weak peripheral association of the protein with
membrane. The ligand-binding cavity of the  -barrel opens towards
the membrane surface in the predicted orientation (Supplementary
Fig. 1
1), similar to ApoD (Eichinger et al., 2007). The membrane-
interacting residues of the protein include the exposed hydrophobic
Phe85 and a large patch of basic residues (Arg46, Arg113, Lys249,
Arg284, Arg287, Arg319 and Arg352).
3.4. Genome-context analysis
The genome context (http://string.embl.de) of NE1406 shows a
predicted functional association with the lipoprotein-releasing system
ATP-binding protein LolD (lolD) and co-occurrence with an ATP-
binding protein ABC transporter (NE1404). A high degree of con-
ﬁdence is predicted for the functional association of many DUF2006
homologs with ATP-dependent ABC transporters, as well as with
other transmembrane proteins including Na
+/H
+ antiporters, sensor
histidine kinases and lipoproteins (e.g. LprI precursor in Myco-
bacterium tuberculosis). The systematic presence of ATP-dependent
cassettes and lipoproteins is compatible with a role for the DUF2006
family in lipid transport, while the presence of numerous signal
transduction genes might indicate expression under speciﬁc condi-
tions, such as environmental stress. Further experiments will be
required in order to functionally characterize NE1406 and to deter-
mine whether it associates with lipids in vitro or in vivo and whether
its transcription is subject to environmental regulation.
The DUF2006 protein family contains over 400 homologs distrib-
uted among trypanosomata, fungi, mycobacteria, bacteroidetes,
rhizobia, Vibrio, spirochaetes, ﬁrmicutes and archaea. Given the wide
phylogenetic presence of the DUF2006 family, if an experimental
connection to lipocalins is determined, this ﬁnding would present the
ﬁrst evidence of a lipocalin-related protein in the Archaea domain
and would settle the question of whether or not this protein family
may have arisen via horizontal transfer to eukaryotic cells from the
endosymbiotic  -proteobacterial ancestor of the mitochondrion
(Bishop, 2000).
The availability of more DUF2006 sequences and structures might
shed light on the evolutionary history of this intriguing protein family.
The information presented here, in combination with further bio-
chemical and biophysical studies, should yield valuable insights into
the functional role of NE1406. Models of NE1406 homologs can be
accessedathttp://www1.jcsg.org/cgi-bin/models/get_mor.pl?key=2ichA.
Additional information about the protein described in this study is
available from TOPSAN (Krishna et al., 2010) at http://www.topsan.
org/explore?PDBid=2ich.
4. Conclusions
NE1406 adopts a lipocalin-like fold with domain duplication.
Analysis based on the calycin-superfamily signature present in the
N-terminal domain reveals a potential binding site, while remote
sequence homology and the genome context suggest involvement in
isoprenoid metabolism and survival under oxidative stress.
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